Ursodex - The IBN SINA Pharmaceutical Industry Ltd.
... mg/kg/day administered in two to four divided doses with food. Dissolution of gallstones: The recommended adult dose is 6-12 mg/kg/day as a single dose at bedtime. Dosing regimen should be adjusted according to each patient's need at the discretion of the physician. Contraindication: Non-functioning ...
... mg/kg/day administered in two to four divided doses with food. Dissolution of gallstones: The recommended adult dose is 6-12 mg/kg/day as a single dose at bedtime. Dosing regimen should be adjusted according to each patient's need at the discretion of the physician. Contraindication: Non-functioning ...
Drug Delivery Employed in Pain Pharmacotherapy
... Describe the technologic approaches used in analgesic drug delivery routes of admin. Describe the physiologic & pharmacokinetic basis for routes of administration Describe products using each of the administration routes, their common clinical use, risks and precautions ...
... Describe the technologic approaches used in analgesic drug delivery routes of admin. Describe the physiologic & pharmacokinetic basis for routes of administration Describe products using each of the administration routes, their common clinical use, risks and precautions ...
PENICILLIN G
... pediatric oral doses are 25 to 50 mg/kg/day divided every 6 to 8 h; pediatric parenteral doses are 300,000 units to 1.2 million units/day given every 3 to 4 h, to a maximum of 50,000 units/kg/dose or 5 million units/dose and 30 million units/day. ...
... pediatric oral doses are 25 to 50 mg/kg/day divided every 6 to 8 h; pediatric parenteral doses are 300,000 units to 1.2 million units/day given every 3 to 4 h, to a maximum of 50,000 units/kg/dose or 5 million units/dose and 30 million units/day. ...
CeleBREX - DavisPlus
... CNS: dizziness, headache, insomnia. CV: MYOCARDIAL INFARCTION, STROKE, THROMBOSIS, edema. GI: GI BLEEDING, abdominal pain, diarrhea, dyspepsia, flatulence, nausea. Derm: EXFOLIATIVE DERMATITIS, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, rash. ...
... CNS: dizziness, headache, insomnia. CV: MYOCARDIAL INFARCTION, STROKE, THROMBOSIS, edema. GI: GI BLEEDING, abdominal pain, diarrhea, dyspepsia, flatulence, nausea. Derm: EXFOLIATIVE DERMATITIS, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, rash. ...
Estrogen New Format 4.0
... conditions listed in column two of the table below. If your menopausal symptoms are severe and interrupt normal living, hormone treatment might provide relief. Take the lowest dose possible for the shortest duration possible. The risks associated with such use appear to be quite low, but definitive ...
... conditions listed in column two of the table below. If your menopausal symptoms are severe and interrupt normal living, hormone treatment might provide relief. Take the lowest dose possible for the shortest duration possible. The risks associated with such use appear to be quite low, but definitive ...
Nimulid Tablet - Panacea Biotec
... 0.12 to 1.03mg/L were still measurable 12 hours after administration, the time at which successive dose is given in the recommended dose regimen. Nimesulide is absorbed at a similar rate and to the same extent whether administered in tablet, suspension or granular form5. Food effects Oral administra ...
... 0.12 to 1.03mg/L were still measurable 12 hours after administration, the time at which successive dose is given in the recommended dose regimen. Nimesulide is absorbed at a similar rate and to the same extent whether administered in tablet, suspension or granular form5. Food effects Oral administra ...
VERGO 16 Presentation Uses Indications Dosage and Administration
... The mechanism of action of betahistine is not known. Pharmacological testing in animals has shown that the blood circulation in the striae vascularis of the inner ear improves, probably by means of a relaxation of the precapillary sphincters of the microcirculation of the inner ear. In further anima ...
... The mechanism of action of betahistine is not known. Pharmacological testing in animals has shown that the blood circulation in the striae vascularis of the inner ear improves, probably by means of a relaxation of the precapillary sphincters of the microcirculation of the inner ear. In further anima ...
Factors that may cause Bleeding with Enoxaparin
... is a possibility of excessive drug exposure in obese patients. LMWHs have many adverse effects and the main one is bleeding. ...
... is a possibility of excessive drug exposure in obese patients. LMWHs have many adverse effects and the main one is bleeding. ...
Carbamazepine Toxicity - Anticonvulsant structurally similar to TCA`s
... Intravenous administration of methylene blue (1–2 mg/kg) as a 1% solution over 5 minutes quickly relieves cyanosis due to methemoglobinemia. Intravenous methylene blue is indicated for methemoglobin fractions over 30% and at lower fractions in patients with anemia or cardiovascular disease. The dose ...
... Intravenous administration of methylene blue (1–2 mg/kg) as a 1% solution over 5 minutes quickly relieves cyanosis due to methemoglobinemia. Intravenous methylene blue is indicated for methemoglobin fractions over 30% and at lower fractions in patients with anemia or cardiovascular disease. The dose ...
Asparaginase
... Monitor patient for allergic reactions and/or anaphylaxis. Contraindicated in patients with a prior history of anaphylactic reaction. L-asparaginase isolated from the Erwinia species may be tried in patients previously treated with E. coli asparaginase, but allergic reactions may still occur. L-Aspa ...
... Monitor patient for allergic reactions and/or anaphylaxis. Contraindicated in patients with a prior history of anaphylactic reaction. L-asparaginase isolated from the Erwinia species may be tried in patients previously treated with E. coli asparaginase, but allergic reactions may still occur. L-Aspa ...
outline26482
... ii) Opiods or Opiates iii) Natural or Synthetic iv) Drug of choice for the treatment of acute moderate to severe pain c) Narcotic Analgesics i) The Basics (1) Controlled Substance Act of 1970 (2) Regulated by: (3) DEA (4) Common Narcotics (5) Morphine (6) The gold standard (7) High side effects and ...
... ii) Opiods or Opiates iii) Natural or Synthetic iv) Drug of choice for the treatment of acute moderate to severe pain c) Narcotic Analgesics i) The Basics (1) Controlled Substance Act of 1970 (2) Regulated by: (3) DEA (4) Common Narcotics (5) Morphine (6) The gold standard (7) High side effects and ...
NON-PRESCRIPTION MEDICINES 4e – UPDATES, NOVEMBER 2010 – MAY 2011 Chapter Page
... exceeding 80 mL and 5–15% of women are thought to be affected to such a degree that treatment should be considered. However, in practice menorrhagia is generally self-diagnosed through a woman’s subjective assessment of blood loss. In January, 2011, tranexamic acid 500 mg filmcoated tablets were mar ...
... exceeding 80 mL and 5–15% of women are thought to be affected to such a degree that treatment should be considered. However, in practice menorrhagia is generally self-diagnosed through a woman’s subjective assessment of blood loss. In January, 2011, tranexamic acid 500 mg filmcoated tablets were mar ...
Dependence potential
... Drug disposition sedative effects occurs within days, however, tolerance to the anxiolytic effects of benzodiazepines takes longer Behavioral to develop. Cross tolerance can occur also. Cross tolerance means that tolerance will Pharmacodynamic develop to other depressants such as barbiturates and al ...
... Drug disposition sedative effects occurs within days, however, tolerance to the anxiolytic effects of benzodiazepines takes longer Behavioral to develop. Cross tolerance can occur also. Cross tolerance means that tolerance will Pharmacodynamic develop to other depressants such as barbiturates and al ...
To Your Hormone Replacement Therapy Consent Form
... Risks associated with estrogen replacement include, but are not limited to: heart attacks, blood clot formation, gallstones, increased risk of uterine cancer (if progesterone is not administered with concurrently) and fibroid tumors. The Women’s Health Initiative study demonstrated increased risk wh ...
... Risks associated with estrogen replacement include, but are not limited to: heart attacks, blood clot formation, gallstones, increased risk of uterine cancer (if progesterone is not administered with concurrently) and fibroid tumors. The Women’s Health Initiative study demonstrated increased risk wh ...
Sildenafil - Women and Newborn Health Service
... Flushing, dyspepsia, headache, swelling of the eyelids, dizziness, visual disturbances, raised intra-ocular pressure, nasal congestion, vomiting, rash, serious cardiovascular disorders (including arrhythmia and sudden cardiac death). Sildenafil should not be used in patients receiving nitrates, thos ...
... Flushing, dyspepsia, headache, swelling of the eyelids, dizziness, visual disturbances, raised intra-ocular pressure, nasal congestion, vomiting, rash, serious cardiovascular disorders (including arrhythmia and sudden cardiac death). Sildenafil should not be used in patients receiving nitrates, thos ...
A Brief History of Bio-identical Hormones Reprinted by permission
... counteract problems associated with menopause. The reason for this type of therapy was that young women’s urine contains the metabolic waste products of estrogen, progesterone, and testosterone. Throughout history you can find references to the use of young women’s urine to help older women with pro ...
... counteract problems associated with menopause. The reason for this type of therapy was that young women’s urine contains the metabolic waste products of estrogen, progesterone, and testosterone. Throughout history you can find references to the use of young women’s urine to help older women with pro ...
PDF
... A total of 10 clinical pregnancies were observed (5 in the day 3 group and 5 in the day 5 group). One pregnancy was ended with clinical abortion in the day 3 group. ...
... A total of 10 clinical pregnancies were observed (5 in the day 3 group and 5 in the day 5 group). One pregnancy was ended with clinical abortion in the day 3 group. ...
File
... It also is the drug of choice for Cryptococcus neoformans after induction therapy with amphotericin B and flucytosine Fluconazole is effective against most forms of mucocutaneous candidiasis. It is commonly used as a single-dose oral treatment for vulvovaginal candidiasis. Fluconazole is available i ...
... It also is the drug of choice for Cryptococcus neoformans after induction therapy with amphotericin B and flucytosine Fluconazole is effective against most forms of mucocutaneous candidiasis. It is commonly used as a single-dose oral treatment for vulvovaginal candidiasis. Fluconazole is available i ...
OFLOMED® 200 mg Tablets Dear patient, Please read
... In case of overdose In case of intake of high doses of this medication, inform your doctor at once and seek emergency medical attention. General measures should be adopted. In case of missed dose Take the missed dose as soon as you remember unless the next intake is near. Go on taking the next sched ...
... In case of overdose In case of intake of high doses of this medication, inform your doctor at once and seek emergency medical attention. General measures should be adopted. In case of missed dose Take the missed dose as soon as you remember unless the next intake is near. Go on taking the next sched ...
Comparison of phototherapy two times and four times a
... (PASI) scores, time (weeks), cumulative UVB dose and number of treatments to clearance. RESULTS: No significant difference was found between the two regimens in the PASI score at the end of treatment, in the proportion of patients whose skin cleared during treatment and in the time to clearance (8 w ...
... (PASI) scores, time (weeks), cumulative UVB dose and number of treatments to clearance. RESULTS: No significant difference was found between the two regimens in the PASI score at the end of treatment, in the proportion of patients whose skin cleared during treatment and in the time to clearance (8 w ...
BuSpar (buspirone) - The Main Line Center for the Family
... BuSpar (buspirone) is an antianxiety medication indicated for management of selected anxiety disorders or for short-term relief of anxiety symptoms. It is not chemically related to the benzodiazepines (e.g., Valium) or barbiturates. In addition, unlike those medications, BuSpar neither produces prom ...
... BuSpar (buspirone) is an antianxiety medication indicated for management of selected anxiety disorders or for short-term relief of anxiety symptoms. It is not chemically related to the benzodiazepines (e.g., Valium) or barbiturates. In addition, unlike those medications, BuSpar neither produces prom ...
Effects of Three Reversal Agents on Detomidine- Induced
... the same cardiac and behavioral changes observed with the parental formulations. Antagonism of central nervous system and cardiovascular effects by ␣2 antagonists after parenteral administration of detomidine have been well characterized. The goal of the current study was to assess the effect of ␣ 2 ...
... the same cardiac and behavioral changes observed with the parental formulations. Antagonism of central nervous system and cardiovascular effects by ␣2 antagonists after parenteral administration of detomidine have been well characterized. The goal of the current study was to assess the effect of ␣ 2 ...
Non hormonal options for menopausal symptoms
... SSRIs are commonly taken to reduce hot flushes and improve mood disorders in women either preferring not to or unable to use hormone therapy. Studies of venlafaxine, a serotonergicnoradrenergic reuptake inhibitor, and paroxetine, an SSRI, demonstrate a moderate reduction in flushes with doses of 37. ...
... SSRIs are commonly taken to reduce hot flushes and improve mood disorders in women either preferring not to or unable to use hormone therapy. Studies of venlafaxine, a serotonergicnoradrenergic reuptake inhibitor, and paroxetine, an SSRI, demonstrate a moderate reduction in flushes with doses of 37. ...
RIFAMPICIN in combination with Isoniazid RIFAMPICIN
... oliguria, dyspnoea and haemolytic anaemia have also been reported in patients taking the drug three times weekly. These reactions usually subside if the regimen is changed to one with daily dosage. Moderate rises in serum concentrations of bilirubin and transaminases, which are common at the outset ...
... oliguria, dyspnoea and haemolytic anaemia have also been reported in patients taking the drug three times weekly. These reactions usually subside if the regimen is changed to one with daily dosage. Moderate rises in serum concentrations of bilirubin and transaminases, which are common at the outset ...
Summer Board review General Medicine Session 3
... The most appropriate treatment for this patient is a 7-day oral regimen of metronidazole (500 mg twice daily). She has bacterial vaginosis (BV), a polymicrobial infection characterized by an overgrowth of multiple anaerobic bacteria. Although BV is not a sexually transmitted infection, risk factors ...
... The most appropriate treatment for this patient is a 7-day oral regimen of metronidazole (500 mg twice daily). She has bacterial vaginosis (BV), a polymicrobial infection characterized by an overgrowth of multiple anaerobic bacteria. Although BV is not a sexually transmitted infection, risk factors ...
Dydrogesterone
Dydrogesterone (INN, USAN, BAN), is also chemically known as 9β,10α-pregna-4,6-diene-3,20-dione. Dydrogesterone (6-dehydro-retroprogesterone) is a hormonally active, non-androgenic steroid that was developed in the 1950s.Dydrogesterone has selective progestational activity and does not inhibit ovulation. The greater rigidity of dydrogesterone also positively affects its selectivity, while natural progesterone is less selective, existing in different conformations that more easily bind to different receptors. As a consequence of its better bioavailability and the progestational activity of its main metabolites (20-, 21- and 16-hydroxy derivatives), the equivalent dose of dydrogesterone is 10–20 times lower than that of oral micronized progesterone.Dydrogesterone is used as an effective, orally active progestogen for gynaecological conditions related to a wide variety of progesterone deficiencies in pregnant women. The molecular structure and pharmacological effects are somewhat similar to endogenous progesterone, although in smaller amounts it is found to be orally active. Its freedom from hormonal effects like those related to corticoid, androgenic, estrogenic, anabolic, and other effects gives dydrogesterone an advantage over other synthesized progestogens.Dydrogesterone when used therapeutically is closely related to its physiological action on the neuro-endocrine control of ovarian function, as well as on the endometrium. This is an indication in all cases of endogeneous progesterone deficiency - relative or absolute. The molecule was licensed for use in several indications, including threatened or recurrent miscarriage, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhoea, irregular cycles, pre-menstrual syndrome and also as a hormone replacement therapy.Dydrogesterone has proven effective in the following conditions associated with progesterone deficiency: Infertility due to luteal insufficiency Threatened miscarriage Habitual or recurrent miscarriage. Menstrual disorders Premenstrual syndrome Endometriosis Dydrogesterone has also been registered as hormone replacement therapy (HRT) to counter-check the negative effects of unopposed estrogen on the endometrium in women with an intact uterus. Dydrogesterone is relatively safe and well tolerated, and does not exhibit the androgenic side effects that are common with some other progestins, like medroxyprogesterone acetate.